SIGMA Brand
Displaying 108851-108900 of 115578 results.
| Sigma Cat.No. | Description |
|---|---|
| SRP0643 | PD-L1 (K124A), FC Fusion, Biotin Labeled recombinant, expressed in HEK 293 cells |
| SRP0644 | PD-L1 (R125A), FC Fusion, Biotin Labeled recombinant, expressed in HEK 293 cells |
| SRP0645 | PD-1, FLAG® -His-Tag, Biotin Labeled recombinant, expressed in HEK 293 cells |
| SRP0648 | ARG1, His-Tag recombinant, expressed in HEK 293 cells |
| SRP0649 | ARG2, His-Tag recombinant, expressed in baculovirus infected Sf9 cells |
| SRP0652 | PD-1 ,FC Fusion (Mouse IgG2A) recombinant, expressed in HEK 293 cells |
| SRP0655 | CD150,FC Fusion, AviTag™ (Human) recombinant, expressed in HEK 293 cells |
| SRP0660 | CD48, FC Fusion ( IgG1), AviTag™ (Human) recombinant, expressed in HEK 293 cells |
| SRP0661 | CBL-B, His-Tag, Biotin Labeled recombinant, expressed in E. coli |
| SRP0662 | CBL-B (Y363F), His-Tag, Biotin Labeled recombinant, expressed in E. coli |
| SRP0663 | CBL-B, HIS- AviTag™ (Human) recombinant, expressed in E. coli |
| SRP0664 | CBL-B, GST-Tag recombinant, expressed in E. coli |
| SRP0666 | IDH2, FLAG® -Tag recombinant, expressed in baculovirus infected Sf9 cells |
| SRP0671 | PD-L1 (CD274), FC Fusion recombinant, expressed in HEK 293 cells |
| SRP0672 | IDO2, His-Tag recombinant, expressed in E. coli |
| SRP0674 | IL-17RA, FC Fusion, Biotin Labeled recombinant, expressed in HEK 293 cells |
| SRP0675 | IL-17A recombinant, expressed in E. coli |
| SRP2001 | TFIIA-p55 human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2002 | TFIIA-p12 human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2003 | TBP (TATA box binding protein) human recombinant, expressed in E. coli, ≥85% (SDS-PAGE) |
| SRP2004 | TFIIE α, p56 human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2005 | TFIIE β, p34 human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2006 | TFIIE, α+β subunits human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2007 | TFIIF (RAP74 subunit) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2008 | TFIIF (RAP30 subunit) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2009 | TFIIF (RAP30+Rap74) human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2010 | TFIIH, native complex human ≥75% (SDS-PAGE) |
| SRP2011 | TFIIH, p62 subunit human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2013 | RNA Polymerase II, C-terminal human recombinant, expressed in E. coli, ≥85% (SDS-PAGE) |
| SRP2014 | RNA Polymerase II, p33 subunit human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2015 | RNA Polymerase II, p14.5 subunit human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2016 | GAL4 [(1-147) - AH] from Saccharomyces cerevisiae recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2017 | GAL4 [(1-147) + VP16 (411-490)] from Saccharomyces cerevisiae human herpesvirus 2 recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2018 | GAL4 [(1-147) + E1A (121-223)] from Saccharomyces cerevisiae canine adenovirus recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2023 | PC4, F77P mutant human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2024 | PC4, serine mutations human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2025 | p52 human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2026 | p75 human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2027 | E2F-1 (RBAP-1) human recombinant, expressed in insect cells, ≥70% (SDS-PAGE) |
| SRP2028 | TFIIA, reconstituted human recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2030 | Sp1 GC-box binding protein human recombinant, expressed in insect cells, ≥75% (SDS-PAGE) |
| SRP2032 | Topo I (C651-765) (C terminal domain) human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2033 | Topo I (197-651) (core domain) human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2034 | Topo I (N1-197) (NTD) human recombinant, expressed in insect cells, ≥85% (SDS-PAGE) |
| SRP2035 | Topo I (Y723F) (mt Y723F) human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2036 | BRG1, wild type human recombinant, expressed in insect cells, ≥80% (SDS-PAGE) |
| SRP2039 | FXR (Farnesoid- recombinant, expressed in E. coli, ≥80% (SDS-PAGE) |
| SRP2042 | LXRα-ligand binding domain (215-667) human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |
| SRP2043 | PPAR, α human recombinant, expressed in E. coli, ≥75% (SDS-PAGE) |
| SRP2045 | PPAR, γ human recombinant, expressed in E. coli, ≥70% (SDS-PAGE) |